{"transactions":[{"id":826640,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":55666,"kind":"person","name":"Maltzman Julia D.","position":1,"cik":"0002052749","reported_name":"Maltzman Julia D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-27T16:10:40.000Z","date":"2026-03-25","kind":"grant","planned":false,"acquired":true,"shares":72555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) 1/48th of the shares shall vest on each of the next forty-eight (48) monthly anniversaries of the grant date, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates."}],"balance_after":72555,"derivative":{"exercise_price":6.81,"expiration_date":"2036-03-24","underlying":"Common Stock","underlying_shares":72555},"source":{"system":"sec-edgar","filing":"0002052749-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2052749/000205274926000003/ownership.xml","form_type":"4"}},{"id":1285402,"issuer":{"id":6860,"kind":"organization","name":"Adicet Bio, Inc."},"owners":[{"id":55666,"kind":"person","name":"Maltzman Julia D.","position":1,"cik":"0002052749","reported_name":"Maltzman Julia D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-04T16:40:14.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on December 7, 2025, and the remainder of the shares shall vest in equal monthly installments for a period of 36 months thereafter, provided that the Reporting Person maintains a service relationship with the Issuer as of the applicable vesting dates."}],"balance_after":750000,"derivative":{"exercise_price":0.885,"expiration_date":"2035-01-30","underlying":"Common Stock","underlying_shares":750000},"source":{"system":"sec-edgar","filing":"0000950170-25-013596","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2052749/000095017025013596/ownership.xml","form_type":"4"}}]}